Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Provided By GlobeNewswire
Last update: Apr 16, 2025
Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes
Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company’s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025
Read more at globenewswire.comNASDAQ:VANI (6/13/2025, 8:00:02 PM)
1.15
-0.04 (-3.36%)
Find more stocks in the Stock Screener
